Literature DB >> 20589520

Takayasu's arteritis: clinical features and outcomes of 125 patients in China.

Xiao-Liang Cong1, Sheng-Ming Dai, Xiang Feng, Zhi-Wei Wang, Qing-Sheng Lu, Liang-Xi Yuan, Xian-Xian Zhao, Dong-Bao Zhao, Zai-Ping Jing.   

Abstract

Takayasu's arteritis (TA) is a chronic inflammation that frequently involves the aorta and its major branches. The clinical features of TA vary in different ethnic populations. The objective of this study is to characterize the clinical features, angiographic findings, and response to treatment of patients with TA in Changhai Hospital, Shanghai, China. The hospital records of 125 patients diagnosed with TA were retrospectively evaluated. Eighty patients were followed for a median duration of 36 months. Females (86.4%) were most frequently affected. The mean age at onset was 26.9 years. Constitutional symptoms were present in only 38.4% of patients. The most common clinical finding was pulse deficit. Histological findings from 12 clinically inactive patients showed active lesions in 58.3%. Angiographic classification showed that type I was the most common, followed by type V and IV. Type I was more common in adult patients than in pediatric patients. Although immunosuppressive treatment induced remission in most patients, over 90% of those who achieved later remission relapsed. Both bypass procedures and angioplasty showed high rates of initial success, but restenosis occurred in 34.7% of bypass procedures and 77.3% of angioplasty procedures. Eight patients died during the follow-up period with the main cause of death being congestive heart failure. Constitutional symptoms were not frequent in our study. Correlation between the clinical assessment of disease activity and histologic findings is often poor in TA. Angiographic findings showed that type I was the most common in our study. Over the longer term, the outcomes of revascularization were superior to angioplasty.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20589520     DOI: 10.1007/s10067-010-1496-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  37 in total

1.  Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification.

Authors:  M-C Park; S-W Lee; Y-B Park; N S Chung; S-K Lee
Journal:  Scand J Rheumatol       Date:  2005 Jul-Aug       Impact factor: 3.641

2.  Angiographic findings of Takayasu arteritis: new classification.

Authors:  A Hata; M Noda; R Moriwaki; F Numano
Journal:  Int J Cardiol       Date:  1996-08       Impact factor: 4.164

3.  Hypersecretion of estrogen in Takayasu's disease.

Authors:  F Numano; T Shimamoto
Journal:  Am Heart J       Date:  1971-05       Impact factor: 4.749

4.  Takayasu's arteritis. An angiographic study with remarks on ethnic distribution in Israel.

Authors:  V Deutsch; L Wexler; H Deutsch
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1974-09

5.  Takayasu arteritis. Treatment and prognosis in a university center in Brazil.

Authors:  E I Sato; D N Lima; B Espirito Santo; F Hata
Journal:  Int J Cardiol       Date:  2000-08-31       Impact factor: 4.164

6.  Takayasu arteritis in Thailand: clinical and imaging features.

Authors:  N Suwanwela; C Piyachon
Journal:  Int J Cardiol       Date:  1996-08       Impact factor: 4.164

7.  Current status of Takayasu arteritis in India.

Authors:  S Jain; S Kumari; N K Ganguly; B K Sharma
Journal:  Int J Cardiol       Date:  1996-08       Impact factor: 4.164

8.  Renal revascularization in Takayasu arteritis-induced renal artery stenosis.

Authors:  Fred A Weaver; S Ram Kumar; Albert E Yellin; Scott Anderson; Douglas B Hood; Vincent L Rowe; Rodanthi C Kitridou; Roy D Kohl; Jason Alexander
Journal:  J Vasc Surg       Date:  2004-04       Impact factor: 4.268

Review 9.  Coronary involvement in Takayasu's arteritis.

Authors:  Moshe Rav-Acha; Leeor Plot; Nathan Peled; Howard Amital
Journal:  Autoimmun Rev       Date:  2007-05-21       Impact factor: 9.754

10.  Takayasu arteritis.

Authors:  G S Kerr; C W Hallahan; J Giordano; R Y Leavitt; A S Fauci; M Rottem; G S Hoffman
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

View more
  23 in total

1.  Impact of revascularization on hypertension in children with Takayasu's arteritis-induced renal artery stenosis: a 21-year review.

Authors:  Taiwo Augustina Ladapo; Priya Gajjar; Mignon McCulloch; Christiaanah Scott; Alp Numanoglu; Peter Nourse
Journal:  Pediatr Nephrol       Date:  2015-02-04       Impact factor: 3.714

2.  Anti-cytokine treatment for Takayasu arteritis: State of the art.

Authors:  Enrico Tombetti; Maria Chiara Di Chio; Silvia Sartorelli; Enrica Bozzolo; Maria Grazia Sabbadini; Angelo A Manfredi; Elena Baldissera
Journal:  Intractable Rare Dis Res       Date:  2014-02

3.  Takayasu arteritis: imaging spectrum at multidetector CT angiography.

Authors:  F P Zhu; S Luo; Z J Wang; Z Y Jin; L J Zhang; G M Lu
Journal:  Br J Radiol       Date:  2012-12       Impact factor: 3.039

Review 4.  Takayasu's arteritis and posterior reversible encephalopathy syndrome: a case-based review.

Authors:  Carlos Rodrigo Camara-Lemarroy; Jackeline Grace Lara-Campos; Eduardo Perez-Contreras; René Rodríguez-Gutiérrez; Dionicio Angel Galarza-Delgado
Journal:  Clin Rheumatol       Date:  2013-01-06       Impact factor: 2.980

5.  Takayasu's arteritis in Arabs.

Authors:  Khader N Mustafa
Journal:  Clin Rheumatol       Date:  2014-05-07       Impact factor: 2.980

6.  Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu's arteritis.

Authors:  Ying Sun; Lili Ma; Lingying Ma; Xiufang Kong; Huiyong Chen; Peng Lv; Jiang Lin; Hao Liu; Yan Yan; Zongfei Ji; Chengde Yang; Shengming Dai; Weiguo Wan; Yaohong Zou; Xuejuan Jin; Lindi Jiang
Journal:  Rheumatol Int       Date:  2017-10-13       Impact factor: 2.631

7.  Analysis of predictive factors for treatment resistance and disease relapse in Takayasu's arteritis.

Authors:  Ying Sun; Lili Ma; Huiyong Chen; Xiufang Kong; Peng Lv; Xiaomin Dai; Zongfei Ji; Chengde Yang; Shengming Dai; Lijun Wu; Yaohong Zou; Jiang Lin; Hongcheng Shi; Qiang Yu; Lindi Jiang
Journal:  Clin Rheumatol       Date:  2018-04-23       Impact factor: 2.980

Review 8.  Amaurosis as an initial presentation of Takayasu arteritis in children.

Authors:  Beatriz Bayardo-Gutiérrez; Marco Antonio Yamazaki-Nakashimada; Ana Luisa Rodríguez-Lozano; Gilberto Gómez-Garza; Francisco Eduardo Rivas-Larrauri; José Alonso Gutiérrez-Hernández; Selma Cecilia Scheffler-Mendoza
Journal:  Rheumatol Int       Date:  2022-04-02       Impact factor: 2.631

9.  Clinical presentation, treatment and outcome of Takayasu's arteritis in southern Chinese: a multicenter retrospective study.

Authors:  Stella Pui Yan Wong; Chi Chiu Mok; Chak Sing Lau; Man Lung Yip; Lai Shan Tam; King Yee Ying; Woon Leung Ng; Kam Hung Ng; Moon Ho Leung; Tsz Yan Lee; Chi Hung To; Ka Lai Lee; Man Choi Wan; Ka Lung Yu; Priscilla Ching Han Wong; Chi Keung Sung; Kwok Fai Lee; Emily Wai Lin Kun
Journal:  Rheumatol Int       Date:  2018-09-04       Impact factor: 2.631

10.  Takayasu's arteritis: Is it a reversible disease? Case Report and Literature Review.

Authors:  Vishnumurthy Shushrutha Hedna; Akhil Patel; Sharathchandra Bidari; Melissa Elder; Brian L Hoh; Anthony Yachnis; Michael F Waters
Journal:  Surg Neurol Int       Date:  2012-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.